Member Info for Odysseus07

VERY STRONG BUY. Approval is "days away". So the fact that the share price is going down means that it's a strong buy. Approval days away for a $1bn in revenue at least. And share price going down? Exactly - what a buying opportunity!!! Buy more for your money with the guarantee it will be over £1 in a matter of days.

Ananda? Ananda? Hello? Thats right.....? Isnt it....? Oh please say yes as i have a lot of money invested, No knowledge.... but a lot of money....

I wouldnt worry. Ananda says EMA approval "days away". So lets be generous. 6 weeks. Otherwise thats then "weeks" not days. EMA approval due by mid Feb and then 60p-£1. More or less guaranteed. Now ive bought in more, lets hit the stars!

Ok, so there is no news on a commercial partner, only another FDA meeting in Feb, money running out nu May 2021, placing likely as no significant revenues until 2022 (even if approval in 2021 in both EMA and US), having to succeed in another trial against a proven PDE5i (the class of drig that viagra cialis and levitra are). A

All that is minor. EMA approval days away and partner on boxing day announced and 60 pe in Jan, £5 in feb with ema approval and £10 in sept with FDA approval. All guaranteed (more or less)

Good luck with your investment surfie.

its a quote from ananda quote on Thursday/Froday

Here is what Ananda said "They receive EU approval 2021 is only days away". Now lets all mark this. It wont e approved even in March. Now everyone, lets mark this. And Ananda in Feb when it's not launched/approved, please let us know why. You have no idea at all.

Lol. Lets make a record and sportsmans bet. You say Q2 2021, I say Q4 2021 (with a feeling it may be q1 2022)

Just read the RNS. Busy day. No real progress made, hence the SP remaining level. So:

1. FDA - another meeting now in Feb. So at best, the timing of the trial will start in March, as expected (ok, neutral). But slightly positive that the FDA minutes backed up the last RNS
2. EMA is "now actively looking" - its been 6 months. Possible delayed by COVID. But i note the very slight weakening of the hope for approval in 2021. Now more likely Q4 2021 earliest, more likely 2022
3. Partner. Sounds like one selected partner down to one (either FUM preferred this one or others dropped out). This must e USA and must eb linked with FDA outcome.

All in all, agree with back..... the SP will do nothing until either more capital needed (dilution and decline nearer to 10p) or partner announced that will fund FUM until FDA trial completed (sept/oct 2021) in which case steep SP rise.

Thats the gamble and pretty much what I have bee saying for a while.

Good luck all. Ody - the liar and deramper lol

Bucolic. In clinical trials, if the treatment is no better than the "placebo" then that is a failure and the product isnt approved. think a sugar pill vs new chemo agent for cancer. Thats a placebo. Med 3000 isnt a placebo, otherwise you have just made FUM bankrupt as they are selling sugar....

Med3000 (or dermasys) is a vehicle that may have a non-pharmacological (i.e. drug treatment effect - GTN was the drug that failed, and hence why FUM have scrapped development). FUM investors are banking on the dermasys solvent having a non pharmacological effect, based on solvent evaporating and that cold effect (like hand gel on hands) stimulating an erection.

That is the product you are investing in. Someone below posted about GTN med2005. Why? That is no longer being developed as commercially it failed as it was no better than the "placebo" as you called it. a placebo is something doctors know ahs no effect, i wouldnt call meed3000 a placebo if i were you.... and had invested heavily in it lol. I note FUM dont call it placebo as that would dilute their company value even more. "Hey guys, we spent 15 years developing a placebo, but give us more money as we really know what we are doing". Idiotic bucolic lol

Not long before the 13p barrier is broken. All it will take is no news on EMA update or a "partner/investor" before Xmas....

Seems odd when some believe EMA approval is "weeks away" and an investor with £6million is days away.... seems to be an odd market reaction to that.......

GTN was med2005 - this has been stopped as no better than just the solvent (Med3000). PLEASE PLEASE, can people understand what they are buying? If you believe in med3000 as a solvent that when it evaporates on the peni1s, stimulates nerves and causes an erection, fine. But do not buy believing you are buying the GTN product. It failed as no better than vehicle med3000 (sometimes mistakenly called a placebo).

Please educate yourselves. It's your investment

Good luck idg69

Dr Nielsen. By the company's own statements, they have enough money until "quarter 2 2021". Money has to be found for the FDA trial (£3million) and running costs until (assuming approval) Med3000 makes any significant money. approval wont be until Q3 earliest f0r europe, and Q1 2022 US. So funding for £3million until end of Q1 2022. So about £6million.

out of the people on here, who thinks MED3000 is an active treatment for ED? because if you do, not even FUM think that. Its a device of non active solvent. That FUM say has a mechanical effect. It is purely a solvent. Fine, if it works. But its not a treatment. The same solvent (Dermasys) is used to dissolve a cannibinoid treatment for pain (in phase 2 trials i thik with FUM). ~
Please do research and know what you are buying. you are not buying a treatment for ED

I don
Pl

lol. The SP is down. The trend is down. Good god. The last RNs it went to 16.5p from 13.5 now back to 14.3. Was 27p or so in june. Very odd for a billion pound product weeks away from approval

whatever. med3000 instead of med2005. You guys never respond to the fundamentals of what i say. You and everyone knew i meant med3000. Explain to me what med300 is? what is a vehicle? Or do you think med3000 has an active ingredient that helps ED?now explain med2005?

You cant, i can. But you pick up on a typo. Oh well. Look at the market reaction to fum.

."I dont think the FDA trial will show it is more effective than the higher doses of viagra and cilalis."

Now I admit it was unclear as I was rushing. What I meant was that the FDA i dont think will show that Med2005 is as effective as the higher doses of viagra and cialis. You can do a broad comparison of treatments / devices eve if viagra is not in the trial (although not scientific). So I meant you can see the results of the FDA trial and make broad comparisons with viagra. You can of course do direct comparisons with cialis as its in the trial. Of course, it is open label (people know what they are taking and so do the people running the trial). Which of course means the possibility of conscious or subconcious bias.

No. I didnt. Read the message again. You idiot.

Hey ho and down she sinks, hey ho and down she sinks....... seems odd that with approval "a matter of weeks away" for a "$1billion pound device" that the share price is down yet again and the the long term trend is gradual decline. seems bizarre to me. Explain

I said cialis. Good grief. I wasnt saying the trial was with viagra. The phase 3 trial showed Med2005 was not as effective (significantly worse) than the higher doses of the ED treatments. Not surprising as MED2005 DOES NOT CONTAIN any active substance. I do hope people understand that. It's a device. The same solvent is used to transport the pain treatment in the other research area.

The HSE was just testing whether FUM could make the MED2005 safely. So what? If they couldnt pass that, then that would have been poor. You guys are so un-objective and blind

Hi spiderman. My guess / hunch would be 60% chance of approval. But I dont think the device will take off and be a blockbuster but will find a niche and become a decent revenue stream. I dont think the FDA trial will show it is more effective than the higher doses of viagra and cilalis. Think it may well match the weakest doses but be less good than the higher doses.

Thats my honest feel.

Ignore sb88, lets see end of Jan if its approved (I promise you, it wont be).

sb88... you are saying matter of weeks for approval? No, stop misleading people.

Spiderman. This is objective: Data and info submitted by FUM in July. No news yet when EAM will get back (they have prioritised covid vaccines). Likely to be January (end of). Then it is highly likely (95%) there will be comments before approval. FUM then need to respond and EMA need to re-look at this response. So earliest approval by EMA is start of Q3 2021. Worst case is 2022. Of course the absolute worst case is np approval.

That is purely objective. A "matter of weeks" for approval is ignorant misleading horse s h it. That would be in January.... it wont be. Guaranteed.